Protean completes vanadium-uranium assaying in Korea

By Meagan Evans. Published at Aug 17, 2018, in Juniors

Protean Energy Ltd (ASX:POW) today announced that it has finalised an assaying program at the Daejon Vanadium Project in South Korea, where it is targeting a significant vanadium Resource.

The 85 hole p-XRF assaying program targeted the entire 8.3 kilometre strike length of the vanadium/uranium mineralisation at the project, hosted within the Daejon shale.

The finalisation of this program enables the estimation of a final JORC (2012) Resource over the entire strike length of the deposit, which will expand on the interim Resource released on 4 July 2018 — estimated across 40% of the deposit.

Strike length of the Daejon vanadium/uranium mineralisation
Strike length of the Daejon vanadium/uranium mineralisation

Results from the final Mineral Resource estimation are expected within the third quarter of 2018. Upon completion of the global Resource POW will advance to test Daejon ore through access granted to the multi-million dollar pilot plant.

Not only is POW developing the multi‐energy mineral Daejon Vanadium Project in South Korea, but it is also focused on the commercialisation of vanadium battery energy storage systems.

Yet it remains a speculative stock and investors and investors should take a cautious approach to any investment decision made with regard to this stock.

News that the assay program has been finalised comes just days after the company announced that it has appointed a specialist new energy expert, Scott Davis, to advise POW on its V-KOR battery development and commercialisation program.

Davis, an energy industry expert with significant experience in product development, sales and marketing and market reform roles in the electricity sector, will help drive the development and commercialisation program for the vanadium flow battery technology.

S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of Maven Capital Pty Ltd (AFSL No. 418504). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.

Conflict of Interest Notice

S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.

Publishers Notice

The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.

Facebook
Twitter
LinkedIn